Hollenshead Stuart bought PRPH

February 17, 2025 · Form 4 insider transaction

Hollenshead Stuart bought 500,000 shares of ProPhase Labs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
500,000
Price
$0.00
Total value
N/A
Role—
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 17, 2025
Filing dateFebruary 21, 2025
Shares owned after500,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Stock option granted as an inducement award. The option vests over a three-year period, with 25% vesting on the date of grant and 25% vesting on each of the next three anniversaries thereafter, subject to the Reporting Person's continued service through each vesting date.

View the original Form 4 on SEC EDGAR